ATP1A3 Gene Alternating Hemiplegia of Childhood Type 2 NGS Genetic DNA Test
Comprehensive Genetic Testing for Neurological Disorders
The ATP1A3 Gene Alternating Hemiplegia of Childhood Type 2 NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics. This advanced testing method utilizes Next-Generation Sequencing (NGS) technology to identify mutations in the ATP1A3 gene, which plays a critical role in neurological function and development. Early and accurate diagnosis through this test can significantly impact treatment outcomes and quality of life for affected children and their families.
What Does This Test Measure and Detect?
This comprehensive genetic test specifically targets the ATP1A3 gene, which encodes the alpha-3 subunit of the Na+/K+ ATPase enzyme. This enzyme is essential for maintaining proper ion balance in nerve cells and is particularly important in brain function. The test detects:
- Pathogenic variants and mutations in the ATP1A3 gene
- Single nucleotide polymorphisms associated with Alternating Hemiplegia of Childhood Type 2
- Deletion and duplication variants that may affect gene function
- Novel genetic changes that could contribute to neurological symptoms
Who Should Consider This Test?
This genetic test is recommended for individuals presenting with symptoms suggestive of Alternating Hemiplegia of Childhood or related neurological conditions:
- Children experiencing recurrent episodes of temporary paralysis affecting one side of the body
- Individuals with movement disorders including dystonia, chorea, or ataxia
- Patients with developmental delays or regression in motor skills
- Children with paroxysmal eye movement abnormalities
- Individuals with autonomic nervous system dysfunction
- Patients with a family history of similar neurological symptoms
Key Benefits of ATP1A3 Genetic Testing
Undergoing this comprehensive genetic analysis provides numerous advantages for patients and families:
- Accurate Diagnosis: Confirms or rules out Alternating Hemiplegia of Childhood Type 2 with high precision
- Personalized Treatment: Enables targeted therapeutic approaches based on genetic findings
- Family Planning: Provides crucial information for genetic counseling and reproductive decisions
- Early Intervention: Facilitates timely management strategies to improve long-term outcomes
- Symptom Management: Helps develop effective strategies for managing episodic symptoms
- Research Contribution: Contributes to ongoing research in neurological genetic disorders
Understanding Your Test Results
Our comprehensive genetic counseling services help you interpret and understand your test results:
- Positive Result: Indicates the presence of a pathogenic variant in the ATP1A3 gene, confirming the diagnosis of Alternating Hemiplegia of Childhood Type 2
- Negative Result: Suggests that no known pathogenic variants were detected in the ATP1A3 gene
- Variant of Uncertain Significance: Identifies genetic changes whose clinical significance is currently unknown
- Carrier Status: Determines if an individual carries one copy of a mutated gene
All results are accompanied by detailed explanations and recommendations from our certified genetic counselors.
Test Pricing and Details
| Test Feature | Details |
|---|---|
| Test Name | ATP1A3 Gene Alternating Hemiplegia of Childhood Type 2 NGS Genetic DNA Test |
| Regular Price | $700 USD |
| Discount Price | $500 USD |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type | Blood, Extracted DNA, or One Drop Blood on FTA Card |
| Testing Method | Next-Generation Sequencing (NGS) Technology |
Nationwide Testing Availability
We have diagnostic centers conveniently located across the United States, serving patients in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, Charlotte, San Francisco, Indianapolis, Seattle, Denver, Washington DC, Boston, El Paso, Nashville, Detroit, Oklahoma City, Portland, Las Vegas, Memphis, Louisville, Baltimore, and Milwaukee.
Take the Next Step Toward Diagnosis
If you or your child are experiencing symptoms that may indicate Alternating Hemiplegia of Childhood Type 2, don’t wait to get answers. Our comprehensive genetic testing provides the clarity needed for proper diagnosis and management. Contact our genetic counseling team today to schedule your test and begin your journey toward understanding and managing this neurological condition.
Call or WhatsApp us today at +1(267) 388-9828 to book your ATP1A3 genetic test and take the first step toward accurate diagnosis and personalized care.
